Compass Therapeutics (CMPX) PT Lowered to $8 at Craig-Hallum
Tweet
Share
E-mailGet Alerts CMPX Hot Sheet
Price: $1.24 -31.87%
Rating Summary:
15 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Rating Summary:
15 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Join SI Premium – FREE
Craig-Hallum analyst Albert Lowe lowered the price target on Compass Therapeutics (NASDAQ: CMPX) to $8.00 (from $15.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Downgrades Compass Therapeutics (CMPX) to Neutral
- Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)
- UBS Downgrades PG&E Corporation (PCG) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
